Washington, DC 20006-5349
HELPLINE
A Phase 3 trial in relapsed mesothelioma patients showed a significant improvement in overall survival and progression-free survival when patients were treated with nivolumab. Nivolumab…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of five new members to the organization’s board of directors. Jessica Blackford-Cleeton – Springfield, Illinois Cheryl Bruner, Esq. – Louisville, Kentucky Randy Krocka – Sheet…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
